These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16461359)

  • 21. Two-step colocalization of MORC3 with PML nuclear bodies.
    Mimura Y; Takahashi K; Kawata K; Akazawa T; Inoue N
    J Cell Sci; 2010 Jun; 123(Pt 12):2014-24. PubMed ID: 20501696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells.
    Sourvinos G; Tavalai N; Berndt A; Spandidos DA; Stamminger T
    J Virol; 2007 Sep; 81(18):10123-36. PubMed ID: 17626080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.
    Bøe SO; Haave M; Jul-Larsen A; Grudic A; Bjerkvig R; Lønning PE
    J Cell Sci; 2006 Aug; 119(Pt 16):3284-95. PubMed ID: 16868026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
    Shishido-Hara Y; Higuchi K; Ohara S; Duyckaerts C; Hauw JJ; Uchihara T
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):299-308. PubMed ID: 18379438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.
    Lallemand-Breitenbach V; Jeanne M; Benhenda S; Nasr R; Lei M; Peres L; Zhou J; Zhu J; Raught B; de Thé H
    Nat Cell Biol; 2008 May; 10(5):547-55. PubMed ID: 18408733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sumoylation of the novel protein hRIP{beta} is involved in replication protein A deposition in PML nuclear bodies.
    Park J; Seo T; Kim H; Choe J
    Mol Cell Biol; 2005 Sep; 25(18):8202-14. PubMed ID: 16135809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear body formation and PML body remodeling by the human cytomegalovirus protein UL35.
    Salsman J; Wang X; Frappier L
    Virology; 2011 Jun; 414(2):119-29. PubMed ID: 21489587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins.
    Jul-Larsen A; Grudic A; Bjerkvig R; Bøe SO
    J Cell Sci; 2009 Apr; 122(Pt 8):1201-10. PubMed ID: 19339552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
    Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
    Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions.
    Wang J; Shiels C; Sasieni P; Wu PJ; Islam SA; Freemont PS; Sheer D
    J Cell Biol; 2004 Feb; 164(4):515-26. PubMed ID: 14970191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stress responses of PML nuclear domains are ablated by ataxin-1 and other nucleoprotein inclusions.
    Dovey CL; Varadaraj A; Wyllie AH; Rich T
    J Pathol; 2004 Aug; 203(4):877-83. PubMed ID: 15258989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of component exchange at PML nuclear bodies.
    Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
    J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
    Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
    J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNF38 encodes a nuclear ubiquitin protein ligase that modifies p53.
    Sheren JE; Kassenbrock CK
    Biochem Biophys Res Commun; 2013 Nov; 440(4):473-8. PubMed ID: 23973461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies.
    Bernardi R; Pandolfi PP
    Nat Rev Mol Cell Biol; 2007 Dec; 8(12):1006-16. PubMed ID: 17928811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the SUMO1 and ubiquitin conjugation pathways during the inhibition of proteasome activity with evidence of SUMO1 recycling.
    Bailey D; O'Hare P
    Biochem J; 2005 Dec; 392(Pt 2):271-81. PubMed ID: 16117725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
    Sivachandran N; Sarkari F; Frappier L
    PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of caspase-2 with the promyelocytic leukemia protein nuclear bodies.
    Tang J; Xie W; Yang X
    Cancer Biol Ther; 2005 Jun; 4(6):645-9. PubMed ID: 15917662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promyelocytic leukemia bodies tether to early endosomes during mitosis.
    Palibrk V; Lång E; Lång A; Schink KO; Rowe AD; Bøe SO
    Cell Cycle; 2014; 13(11):1749-55. PubMed ID: 24675887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PML nuclear bodies.
    Lallemand-Breitenbach V; de Thé H
    Cold Spring Harb Perspect Biol; 2010 May; 2(5):a000661. PubMed ID: 20452955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.